177 related articles for article (PubMed ID: 9007670)
1. Regional hemodynamic dose-response of lemakalim and glybenclamide in anesthetized rats.
Smits GJ; Perrone MH; Cox BF
J Cardiovasc Pharmacol; 1997 Jan; 29(1):49-56. PubMed ID: 9007670
[TBL] [Abstract][Full Text] [Related]
2. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ
Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
[TBL] [Abstract][Full Text] [Related]
3. Halothane and enflurane attenuate pulmonary vasodilation mediated by adenosine triphosphate-sensitive potassium channels compared to the conscious state.
Seki S; Sato K; Nakayama M; Murray PA
Anesthesiology; 1997 Apr; 86(4):923-35. PubMed ID: 9105237
[TBL] [Abstract][Full Text] [Related]
4. Effects of glibenclamide on the regional haemodynamic actions of alpha-trinositol and its influence on responses to vasodilators in conscious rats.
Gardiner SM; Kemp PA; March JE; Fallgren B; Bennett T
Br J Pharmacol; 1996 Feb; 117(3):507-515. PubMed ID: 8821541
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.
D'Alonzo AJ; Grover GJ; Darbenzio RB; Sewter JC; Hess TA; Dzwonczyk S; Sleph PG
Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631
[TBL] [Abstract][Full Text] [Related]
6. Effects of a K+ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine.
Shen YT; Vatner SF
J Pharmacol Exp Ther; 1993 May; 265(2):1026-37. PubMed ID: 8496801
[TBL] [Abstract][Full Text] [Related]
7. Halothane attenuates endothelium-dependent pulmonary vasorelaxant response to lemakalim, an adenosine triphosphate (ATP)-sensitive potassium channel agonist.
Seki S; Horibe M; Murray PA
Anesthesiology; 1997 Sep; 87(3):625-34. PubMed ID: 9316969
[TBL] [Abstract][Full Text] [Related]
8. Role of ATP-sensitive potassium channels in ovine fetal pulmonary vascular tone.
Cornfield DN; McQueston JA; McMurtry IF; Rodman DM; Abman SH
Am J Physiol; 1992 Nov; 263(5 Pt 2):H1363-8. PubMed ID: 1443190
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310.
Shin HS; Seo HW; Yoo SE; Lee BH
Pharmacology; 1998 Mar; 56(3):111-24. PubMed ID: 9532610
[TBL] [Abstract][Full Text] [Related]
10. Lemakalim attenuates hypocapnia- and dry air-induced bronchoconstriction in canine peripheral airways.
Lindeman KS; Freed AN
J Appl Physiol (1985); 1993 Jul; 75(1):86-92. PubMed ID: 8376305
[TBL] [Abstract][Full Text] [Related]
11. Influence of lemakalim on the pulmonary vascular bed of the cat.
Hood JS; McMahon TJ; Kadowitz PJ
Eur J Pharmacol; 1991 Sep; 202(1):101-4. PubMed ID: 1786796
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic profile of SKP-450, a new potassium-channel activator.
Lee BH; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1998 Jan; 31(1):85-94. PubMed ID: 9456282
[TBL] [Abstract][Full Text] [Related]
14. Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia.
Galiñanes M; Shattock MJ; Hearse DJ
Cardiovasc Res; 1992 Nov; 26(11):1063-8. PubMed ID: 1291083
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T
Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167
[TBL] [Abstract][Full Text] [Related]
16. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
Cavero I; Mondot S; Mestre M
J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353
[TBL] [Abstract][Full Text] [Related]
17. Cromakalim and lemakalim activate Ca(2+)-dependent K+ channels in canine colon.
Carl A; Bowen S; Gelband CH; Sanders KM; Hume JR
Pflugers Arch; 1992 May; 421(1):67-76. PubMed ID: 1630885
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular responses to glibenclamide during endotoxaemia in the pig.
Vanelli G; Hussain SN; Dimori M; Aguggini G
Vet Res Commun; 1997 Apr; 21(3):187-200. PubMed ID: 9090046
[TBL] [Abstract][Full Text] [Related]
19. Effect of an ATP sensitive potassium channel opener, levcromakalim, on coronary arterial microvessels in the beating canine heart.
Sato K; Kanatsuka H; Sekiguchi N; Akai K; Wang Y; Sugimura A; Kumagai T; Komaru T; Shirato K
Cardiovasc Res; 1994 Dec; 28(12):1780-6. PubMed ID: 7867030
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic profiles of YM934, a novel potassium channel opener.
Uchida W; Masuda N; Taguchi T; Shibasaki K; Shirai Y; Asano M; Matsumoto Y; Tsuzuki R; Fujikura T; Takenaka T
J Cardiovasc Pharmacol; 1994 Feb; 23(2):180-7. PubMed ID: 7511745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
